Analysis of the Safety and Effectiveness of Lenvatinib + TACE-HAIC + PD-1 Inhibitor for Intermediate and Advanced Hepatocellular Carcinoma
Yuguang Yang, Hui Tang, Cong Mai, Xin Zhang, Jiawen Kuang, Yunqiang Tang
Topics & Concepts
Hepatocellular carcinomaLenvatinibSorafenibMedicineInternal medicineAdverse effectGastroenterologyLiver cancerStage (stratigraphy)CarcinomaRetrospective cohort studySurgeryPaleontologyBiologyHepatocellular Carcinoma Treatment and PrognosisCancer, Lipids, and MetabolismRenal cell carcinoma treatment